Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Cell Endocrinol ; 283(1-2): 49-57, 2008 Feb 13.
Article in English | MEDLINE | ID: mdl-18177995

ABSTRACT

After the Women's Health Initiative found that the risks of hormone therapy outweighed the benefits, a need for alternative drugs to treat menopausal symptoms has emerged. We explored the possibility that botanical agents used in Traditional Chinese Medicine for menopausal symptoms contain ERbeta-selective estrogens. We previously reported that an extract containing 22 herbs, MF101 has ERbeta-selective properties. In this study we isolated liquiritigenin, the most active estrogenic compound from the root of Glycyrrhizae uralensis Fisch, which is one of the plants found in MF101. Liquiritigenin activated multiple ER regulatory elements and native target genes with ERbeta but not ERalpha. The ERbeta-selectivity of liquiritigenin was due to the selective recruitment of the coactivator steroid receptor coactivator-2 to target genes. In a mouse xenograph model, liquiritigenin did not stimulate uterine size or tumorigenesis of MCF-7 breast cancer cells. Our results demonstrate that some plants contain highly selective estrogens for ERbeta.


Subject(s)
Estrogen Receptor beta/agonists , Flavanones/pharmacology , Glycyrrhiza/metabolism , Selective Estrogen Receptor Modulators/pharmacology , Animals , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Estrogen Receptor alpha/metabolism , Female , Flavanones/chemistry , Humans , Mice , Mice, Nude , Nuclear Receptor Coactivator 2/metabolism , Transcription, Genetic/drug effects , Transfection , Uterus/cytology , Uterus/drug effects , Xenograft Model Antitumor Assays
SELECTION OF CITATIONS
SEARCH DETAIL
...